Quarterly Results FY2020 (April 2020-March 2021)

Document		Q1	Q2	Q3	Q4
Press Release
Quarterly Financial Report
Presentation (for Investors)
Databook
Highlight Video
Underlying Core Reconciliation
Earnings FAQs
Clinical Trial Summary		—	—	—
Financial Statements (Tokyo Stock Exchange filing)
Annual Securities Report/ Quarterly Securities Report *
Form 20-F (SEC filing)		—	—	—

For Media	Q1	Q2	Q3	Q4
Presentation	—		—

* The English version of the Annual Securities Report/Quarterly Securities Report is provided as a reference material to assist foreign investors in understanding the Securities Report, which was filed with Japanese FSA (Financial Services Agency). We do not provide assurance about the accuracy, validity, or coverage of the English translation of this document, and if the description and explanation of this document differs from those of the Japanese Annual Securities Report/Quarterly Securities Report which was filed, the Securities Report in Japanese shall prevail.